Cooper Total Long-Term Assets 2010-2024 | COO

Cooper total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Cooper total long-term assets for the quarter ending July 31, 2024 were $10.181B, a 1.95% increase year-over-year.
  • Cooper total long-term assets for 2023 were $9.954B, a 0.05% decline from 2022.
  • Cooper total long-term assets for 2022 were $9.959B, a 22.33% increase from 2021.
  • Cooper total long-term assets for 2021 were $8.141B, a 49.01% increase from 2020.
Cooper Annual Total Long-Term Assets
(Millions of US $)
2023 $9,954
2022 $9,959
2021 $8,141
2020 $5,463
2019 $5,111
2018 $5,022
2017 $3,906
2016 $3,542
2015 $3,618
2014 $3,667
2013 $2,390
2012 $2,284
2011 $2,084
2010 $2,034
2009 $2,048
Cooper Quarterly Total Long-Term Assets
(Millions of US $)
2024-07-31 $10,181
2024-04-30 $10,188
2024-01-31 $10,239
2023-10-31 $9,954
2023-07-31 $9,986
2023-04-30 $9,940
2023-01-31 $9,984
2022-10-31 $9,959
2022-07-31 $9,954
2022-04-30 $10,040
2022-01-31 $9,964
2021-10-31 $8,141
2021-07-31 $8,136
2021-04-30 $7,691
2021-01-31 $7,625
2020-10-31 $5,463
2020-07-31 $5,427
2020-04-30 $5,344
2020-01-31 $5,399
2019-10-31 $5,111
2019-07-31 $5,022
2019-04-30 $5,067
2019-01-31 $5,106
2018-10-31 $5,022
2018-07-31 $5,068
2018-04-30 $5,142
2018-01-31 $5,093
2017-10-31 $3,906
2017-07-31 $3,851
2017-04-30 $3,792
2017-01-31 $3,773
2016-10-31 $3,542
2016-07-31 $3,663
2016-04-30 $3,686
2016-01-31 $3,557
2015-10-31 $3,618
2015-07-31 $3,608
2015-04-30 $3,593
2015-01-31 $3,549
2014-10-31 $3,667
2014-07-31 $2,472
2014-04-30 $2,457
2014-01-31 $2,414
2013-10-31 $2,390
2013-07-31 $2,301
2013-04-30 $2,291
2013-01-31 $2,289
2012-10-31 $2,284
2012-07-31 $2,256
2012-04-30 $2,052
2012-01-31 $2,044
2011-10-31 $2,084
2011-07-31 $2,072
2011-04-30 $2,087
2011-01-31 $2,069
2010-10-31 $2,034
2010-07-31 $2,012
2010-04-30 $2,016
2010-01-31 $2,025
2009-10-31 $2,048
2009-07-31 $2,063
2009-04-30 $2,022
2009-01-31 $2,014
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.075B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.108B 21.59
Becton Dickinson (BDX) United States $64.746B 17.02
Cardinal Health (CAH) United States $29.487B 15.99
West Pharmaceutical Services (WST) United States $22.928B 46.83
Labcorp (LH) United States $20.046B 16.62
Align Technology (ALGN) United States $16.863B 32.27
Henry Schein (HSIC) United States $9.361B 17.83
Merit Medical Systems (MMSI) United States $6.139B 31.35
DENTSPLY SIRONA (XRAY) United States $3.731B 10.15
CONMED (CNMD) United States $2.314B 19.31
Patterson (PDCO) United States $1.803B 9.52
STAAR Surgical (STAA) United States $1.315B 48.51
Lifevantage (LFVN) United States $0.178B 23.67
Pro-Dex (PDEX) United States $0.152B 30.36